Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Boryung Pharmaceutical Co., Ltd.

    Client Virtual Booth

    BORYUNG PHARMACEUTICAL CO., LTD

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Boryung Pharmaceutical Co., Ltd
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Boryeong Building, 136, Changgyeonggung-ro, Jongno-gu, Seoul
    Telephone
    Telephone
    82 274 043 47
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://boryung.co.kr/en/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Boryung Launches Alcohol-free Breast Cancer Drug

    Details:

    Ditaxel (docetaxel) is an antineoplastic agent that acts by disrupting the microtubular network in cells that is essential for mitotic and interphase cellular functions, by binding to free tubulin and promotes its assembly into stable microtubules while inhibiting their disassembly.


    Lead Product(s): Docetaxel

    Therapeutic Area: Oncology Product Name: Docetaxel-Generic

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 29, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Boryung Pharmaceutical Announces Superior Results for Plitidepsin (Aplidin®) Against SARS-CoV-2

    Details:

    Plitidepsin has showed 2,400~2,800 times higher anti-viral activity than remdesivir.


    Lead Product(s): Plitidepsin

    Therapeutic Area: Infections and Infectious Diseases Product Name: Aplidin

    Highest Development Status: Phase IProduct Type: Small molecule

    Partner/Sponsor/Collaborator: PharmaMar

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 02, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search